- Population pharmacokinetics of tobramycin in patients with and without cystic fibrosisStefanie Hennig
School of Pharmacy, University of Queensland, Brisbane, Pharmacy Australia Centre of Excellence PACE, 20 Cornwall Street, Woolloongabba QLD 4102, Australia
Clin Pharmacokinet 52:289-301. 2013..The objectives of this study were to identify covariates which explain pharmacokinetic variability and to examine whether having the disease CF in itself alters these relationships and drug dose requirements...
- Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyStefanie Hennig
School of Pharmacy, The University of Queensland, Brisbane, Australia
Br J Clin Pharmacol 65:502-10. 2008..In the publications no simulations were provided to show any new directions or evaluate current therapy...